History and Use of Del Nido Cardioplegia Solution at Boston Children's Hospital

Overview

Journal J Extra Corpor Technol

Publisher EDP Sciences

Specialties Biotechnology
General Surgery
Health Services

Date 2012 Dec 4

PMID 23198389

Citations 103

Authors

Gregory S Matte

Pedro J Del Nido

Affiliations

Soon will be listed here.

Abstract

Cardioplegia is an integral and essential method of myocardial protection for patients of all ages requiring cardiac surgery in which the heart must be stopped. Numerous cardioplegia solutions and delivery methods have been developed. The del Nido cardioplegia solution has been in use for 18 years at Boston Children's Hospital. This is a unique four parts crystalloid to one part whole blood formulation that is generally used in a single-dose fashion. Although the formulation was originally developed for use in pediatric and infant patients, its use for adult cardiac surgery has been expanding. National and international inquiries to our institution regarding this cardioplegia have been increasing over the last 2 years. We present the developmental history, supporting theory, and current protocol for use of what is now referred to as del Nido cardioplegia.

Citing Articles

Single-dose modified bloodless del Nido cardioplegia for minimally invasive cardiac surgery.

Lee H, Kim J, Yoo J Front Cardiovasc Med. 2025; 12:1448310.

PMID: 40071232 PMC: 11893588. DOI: 10.3389/fcvm.2025.1448310.

Evaluating the need for magnesium administration following cardioplegic arrest with del Nido cardioplegia solution.

Whittaker Striker C, Reagor J J Extra Corpor Technol. 2025; 57(1):9-13.

PMID: 40053852 PMC: 11888594. DOI: 10.1051/ject/2024033.

Serum Lidocaine Levels in Adult Patients Undergoing Cardiac Surgery With del Nido Cardioplegia.

Aronowitz D, Bocchieri K, Hartman A, Yu P Ann Thorac Surg Short Rep. 2025; 2(2):302-305.

PMID: 39790167 PMC: 11708330. DOI: 10.1016/j.atssr.2023.12.014.

Traditional vs. modified Ringer lactate-based del Nido cardioplegia impacts on clinical outcomes in patients undergoing coronary artery bypass grafting: Results from a prospective, randomized, blinded trial.

Kachoueian N, Janghorban S, Gorjipour F, Torkashvand M, Mahjoob M, Aslani H J Extra Corpor Technol. 2024; 56(4):159-166.

PMID: 39718017 PMC: 11667680. DOI: 10.1051/ject/2024010.

Outcomes of Del Nido and hyperkalemic blood cardioplegia in adult cardiac surgery with prolonged aortic cross-clamp times★.

Szpytma M, Gimpel D, Ross J, Newland R, Crouch G, Rice G J Extra Corpor Technol. 2024; 56(4):149-158.

PMID: 39705579 PMC: 11661786. DOI: 10.1051/ject/2024029.

References

ISERI L, FRENCH J . Magnesium: nature's physiologic calcium blocker. Am Heart J. 1984; 108(1):188-93. DOI: 10.1016/0002-8703(84)90572-6. View

Bove E, Stammers A . Recovery of left ventricular function after hypothermic global ischemia. Age-related differences in the isolated working rabbit heart. J Thorac Cardiovasc Surg. 1986; 91(1):115-22. View

Caputo M, Modi P, Imura H, Pawade A, Parry A, Suleiman M . Cold blood versus cold crystalloid cardioplegia for repair of ventricular septal defects in pediatric heart surgery: a randomized controlled trial. Ann Thorac Surg. 2002; 74(2):530-4; discussion 535. DOI: 10.1016/s0003-4975(02)03695-0. View

Rebeyka I, Bush B, Del Nido P, Mickle D, Romaschin A, Wilson G . Calcium paradox in an in vivo model of multidose cardioplegia and moderate hypothermia. Prevention with diltiazem or trace calcium levels. J Thorac Cardiovasc Surg. 1990; 99(3):475-83. View

Chambers D, Hearse D . Developments in cardioprotection: "polarized" arrest as an alternative to "depolarized" arrest. Ann Thorac Surg. 1999; 68(5):1960-6. DOI: 10.1016/s0003-4975(99)01020-6. View

OBlenes S, Hancock Friesen C, Ali A, Howlett S . Protecting the aged heart during cardiac surgery: the potential benefits of del Nido cardioplegia. J Thorac Cardiovasc Surg. 2010; 141(3):762-70. DOI: 10.1016/j.jtcvs.2010.06.004. View

Bilfinger T, Moeller J, Kurusz M, Grimson R, Anagnostopoulos C . Pediatric myocardial protection in the United States: a survey of current clinical practice. Thorac Cardiovasc Surg. 1992; 40(4):214-8. DOI: 10.1055/s-2007-1020153. View

Ohkado A, Cao-Danh H, Sommers K, Del Nido P . Evaluation of highly buffered low-calcium solution for long-term preservation of the heart. Comparison with University of Wisconsin solution. J Thorac Cardiovasc Surg. 1994; 108(4):762-71. View

Baker J, Boerboom L, Olinger G . Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium. J Thorac Cardiovasc Surg. 1988; 96(5):717-24. View

10.

Hiramatsu T, Zund G, Schermerhorn M, Shinoka T, Miura T, Mayer Jr J . Age differences in effects of hypothermic ischemia on endothelial and ventricular function. Ann Thorac Surg. 1995; 60(6 Suppl):S501-4. DOI: 10.1016/0003-4975(95)00814-4. View

11.

Del Nido P, Wilson G, Mickle D, Bush B, Rebeyka I, Klement P . The role of cardioplegic solution buffering in myocardial protection. A biochemical and histopathological assessment. J Thorac Cardiovasc Surg. 1985; 89(5):689-99. View

12.

Kempsford R, Hearse D . Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart. J Thorac Cardiovasc Surg. 1989; 97(6):856-63. View

13.

Sawa Y, Matsuda H, Shimazaki Y, Kadoba K, Onishi S, Nakada T . Comparison of single dose versus multiple dose crystalloid cardioplegia in neonate. Experimental study with neonatal rabbits from birth to 2 days of age. J Thorac Cardiovasc Surg. 1989; 97(2):229-34. View

14.

Braunwald E, Kloner R . Myocardial reperfusion: a double-edged sword?. J Clin Invest. 1985; 76(5):1713-9. PMC: 424191. DOI: 10.1172/JCI112160. View

15.

Magovern J, Pae Jr W, Waldhausen J . Protection of the immature myocardium. An experimental evaluation of topical cooling, single-dose, and multiple-dose administration of St. Thomas' Hospital cardioplegic solution. J Thorac Cardiovasc Surg. 1988; 96(3):408-13. View

16.

Suaudeau J, Shaffer B, Daggett W, Austen W, Erdmann 3rd A . Role of procaine and washed red cells in the isolated dog heart perfused at 5 degrees C. J Thorac Cardiovasc Surg. 1982; 84(6):886-96. View

17.

Kohman L, Veit L . Single-dose versus multidose cardioplegia in neonatal hearts. J Thorac Cardiovasc Surg. 1994; 107(6):1512-8. View

18.

Allen B . Pediatric myocardial protection: where do we stand?. J Thorac Cardiovasc Surg. 2004; 128(1):11-3. DOI: 10.1016/j.jtcvs.2004.03.017. View

19.

Dobson G, Jones M . Adenosine and lidocaine: a new concept in nondepolarizing surgical myocardial arrest, protection, and preservation. J Thorac Cardiovasc Surg. 2004; 127(3):794-805. DOI: 10.1016/s0022-5223(03)01192-9. View

20.

Amark K, Berggren H, Bjork K, Ekroth A, Ekroth R, Nilsson K . Blood cardioplegia provides superior protection in infant cardiac surgery. Ann Thorac Surg. 2005; 80(3):989-94. DOI: 10.1016/j.athoracsur.2005.03.095. View